fda compounding semaglutide warning letters news September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines FDA Moves to Restrict Mass-Marketed

Supplement marketers really feel like we're going to open the paper or turn on the radio one day and find out our products are non-compliant, says Jeff Cohen, co-founder of the American Peptide Association.

Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles, cannot seem to shed the pounds hurting their health.

A succinct review Science Magazine | 33 comments on LinkedIn

CagriSema and Amycretin work on the GLP-1 and amylin receptors, Retrarutide on GLP-1, GIP and glucagon, Survodutide, Mazdutide, Pemvidutide and Efinopegdutide on GLP-1 and glucagon and still more are coming

Explore the pros and cons of GLP-1 medications for weight management in this informative blog